Dr. Peter Antall, Chief Medical Officer at Brightline, shares his thoughts on vaccinating children against Covid. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Editor-in-Chief Emeritus Matt Winkler discuss why Rivian, a company with no sales, is worth $150 billion. Peter Atwater, Adjunct Professor of Economics at William & Mary, discusses the economic vulnerability Americans are experiencing. And We Drive to the Close with Alan Zafran, Co-CEO at IEQ Capital.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Dr. Peter Antall, Chief Medical Officer at Brightline, shares his thoughts on vaccinating children against Covid. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Editor-in-Chief Emeritus Matt Winkler discuss why Rivian, a company with no sales, is worth $150 billion. Peter Atwater, Adjunct Professor of Economics at William &amp; Mary, discusses the economic vulnerability Americans are experiencing. And We Drive to the Close with Alan Zafran, Co-CEO at IEQ Capital.Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Rivian’s IPO Is Ultimate Validation of Tesla

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d6f094b1-966f-444b-ab19-ae2b001d82fe/transcript

Advertisement